THE STANFORD EXPERIENCE WITH COMBINED PROCARBAZINE, ALKERAN AND VINBLASTINE (PAVE) AND RADIOTHERAPY FOR LOCALLY EXTENSIVE AND ADVANCED STAGE HODGKINS-DISEASE
Horning, S. J., Ang, P. T., Hoppe, R. T., & Rosenberg, S. A. (1992). THE STANFORD EXPERIENCE WITH COMBINED PROCARBAZINE, ALKERAN AND VINBLASTINE (PAVE) AND RADIOTHERAPY FOR LOCALLY EXTENSIVE AND ADVANCED STAGE HODGKINS-DISEASE. ANNALS OF ONCOLOGY, 3(9), 747–754.

Stage I and II follicular non-Hodgkin's lymphoma: Long-term follow-up of no initial therapy
Advani, R., Rosenberg, S. A., & Horning, S. J. (2004). Stage I and II follicular non-Hodgkin's lymphoma: Long-term follow-up of no initial therapy. JOURNAL OF CLINICAL ONCOLOGY, 22(8), 1454–1459.

REDUCING THE TOXICITY OF THE COMBINED MODALITY THERAPY OF FAVORABLE STAGE HODGKINS-DISEASE
Rosenberg, S. A. (1992). REDUCING THE TOXICITY OF THE COMBINED MODALITY THERAPY OF FAVORABLE STAGE HODGKINS-DISEASE. EUROPEAN JOURNAL OF CANCER, 28A(8-9), 1379–1380.

Splenic diffuse large B-cell lymphoma in a patient with type 1 Gaucher disease: diagnostic and therapeutic challenges
Brody, J. D., Advani, R., Shin, L. K., Bingham, D. B., & Rosenberg, S. A. (2006). Splenic diffuse large B-cell lymphoma in a patient with type 1 Gaucher disease: diagnostic and therapeutic challenges. ANNALS OF HEMATOLOGY, 85(11), 817–20.

Impact of positive positron emission tomography on prediction of freedom from progression after Stanford V chemotherapy in Hodgkin's disease
Advani, R., Maeda, L., Lavori, P., Quon, A., Hoppe, R., Breslin, S., … Horning, S. J. (2007). Impact of positive positron emission tomography on prediction of freedom from progression after Stanford V chemotherapy in Hodgkin's disease. JOURNAL OF CLINICAL ONCOLOGY, 25(25), 3902–7.

Dynamic CD8 T-Cell Responses to Tumor-Associated Epstein-Barr Virus Antigens in Patients With Epstein-Barr Virus-Negative Hodgkin's Disease
Kohrt, H., Johannsen, A., Hoppe, R., Horning, S. J., Rosenberg, S. A., Advani, R., & Lee, P. P. (2009). Dynamic CD8 T-Cell Responses to Tumor-Associated Epstein-Barr Virus Antigens in Patients With Epstein-Barr Virus-Negative Hodgkin's Disease. ONCOLOGY RESEARCH, 18(5-6), 287–92.

THE CONTINUING CHALLENGE OF HODGKINS-DISEASE
Rosenberg, S. A. (1991). THE CONTINUING CHALLENGE OF HODGKINS-DISEASE. Presented at the 4TH INTERNATIONAL CONF ON MALIGNANT LYMPHOMA, LUGANO,SWITZERLAND: KLUWER ACADEMIC PUBL.

Rare presentation of classical Hodgkin lymphoma with a clonal T-cell receptor gene rearrangement in the tissue
Nguyen, T. T., Warnke, R. A., Seo, K., Rosenberg, S. A., & Arber, D. A. (2010). Rare presentation of classical Hodgkin lymphoma with a clonal T-cell receptor gene rearrangement in the tissue. LEUKEMIA & LYMPHOMA, 51(7), 1356–1359.

STAGE I-IIIA NON-BULKY HODGKIN'S LYMPHOMA. IS FURTHER DISTINCTION BASED ON PROGNOSTIC FACTORS USEFUL? THE STANFORD EXPERIENCE
Advani, R. H., Hoppe, R. T., Maeda, L. S., Baer, D. M., Mason, J., Rosenberg, S. A., & Horning, S. J. (2011). STAGE I-IIIA NON-BULKY HODGKIN'S LYMPHOMA. IS FURTHER DISTINCTION BASED ON PROGNOSTIC FACTORS USEFUL? THE STANFORD EXPERIENCE. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 81(5), 1374–79.

CEPP(B) - AN EFFECTIVE AND WELL-TOLERATED REGIMEN IN POOR-RISK, AGGRESSIVE NON-HODGKINS-LYMPHOMA
Chao, N. J., Rosenberg, S. A., & Horning, S. J. (1990). CEPP(B) - AN EFFECTIVE AND WELL-TOLERATED REGIMEN IN POOR-RISK, AGGRESSIVE NON-HODGKINS-LYMPHOMA. BLOOD, 76(7), 1293–1298.

Efficacy of abbreviated Stanford V chemotherapy and involved-field radiotherapy in early-stage Hodgkin lymphoma: mature results of the G4 trial
Advani, R. H., Hoppe, R. T., Baer, D., Mason, J., Warnke, R., Allen, J., … Horning, S. J. (2013). Efficacy of abbreviated Stanford V chemotherapy and involved-field radiotherapy in early-stage Hodgkin lymphoma: mature results of the G4 trial. ANNALS OF ONCOLOGY, 24(4), 1044–48.

Risk of Therapy-Related Secondary Leukemia in Hodgkin Lymphoma: The Stanford University Experience Over Three Generations of Clinical Trials
Koontz, M. Z., Horning, S. J., Balise, R., Greenberg, P. L., Rosenberg, S. A., Hoppe, R. T., & Advani, R. H. (2013). Risk of Therapy-Related Secondary Leukemia in Hodgkin Lymphoma: The Stanford University Experience Over Three Generations of Clinical Trials. JOURNAL OF CLINICAL ONCOLOGY, 31(5), 592–98.

VINBLASTINE, BLEOMYCIN, AND METHOTREXATE - AN EFFECTIVE ADJUVANT IN FAVORABLE HODGKINS-DISEASE
Horning, S. J., Hoppe, R. T., Hancock, S. L., & Rosenberg, S. A. (1988). VINBLASTINE, BLEOMYCIN, AND METHOTREXATE - AN EFFECTIVE ADJUVANT IN FAVORABLE HODGKINS-DISEASE. JOURNAL OF CLINICAL ONCOLOGY, 6(12), 1822–31.

HODGKINS-DISEASE - CHALLENGES FOR THE FUTURE
Rosenberg, S. A. (1989). HODGKINS-DISEASE - CHALLENGES FOR THE FUTURE. CANCER RESEARCH, 49(4), 767–769.

Current Stanford clinical trials for Hodgkin's disease.
Hoppe, R. T., Horning, S. J., Hancock, S. L., & Rosenberg, S. A. (1989). Current Stanford clinical trials for Hodgkin's disease. Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progrès Dans Les Recherches Sur Le Cancer, 117, 182–90.

PROGNOSTIC INDICATORS OF LAPAROTOMY FINDINGS IN CLINICAL STAGE-I-II SUPRADIAPHRAGMATIC HODGKINS-DISEASE
LEIBENHAUT, M. H., Hoppe, R. T., Efron, B., Halpern, J., Nelsen, T., & Rosenberg, S. A. (1989). PROGNOSTIC INDICATORS OF LAPAROTOMY FINDINGS IN CLINICAL STAGE-I-II SUPRADIAPHRAGMATIC HODGKINS-DISEASE. JOURNAL OF CLINICAL ONCOLOGY, 7(1), 81–91.

INTERCURRENT DEATH AFTER HODGKIN DISEASE THERAPY IN RADIOTHERAPY AND ADJUVANT MOPP TRIALS
Hancock, S. L., Hoppe, R. T., Horning, S. J., & Rosenberg, S. A. (1988). INTERCURRENT DEATH AFTER HODGKIN DISEASE THERAPY IN RADIOTHERAPY AND ADJUVANT MOPP TRIALS. ANNALS OF INTERNAL MEDICINE, 109(3), 183–89.

EXPLORATORY LAPAROTOMY AND SPLENECTOMY FOR HODGKINS-DISEASE - A COMMENTARY
Rosenberg, S. A. (1988). EXPLORATORY LAPAROTOMY AND SPLENECTOMY FOR HODGKINS-DISEASE - A COMMENTARY. JOURNAL OF CLINICAL ONCOLOGY, 6(4), 574–575.

PRELIMINARY-OBSERVATIONS ON EFFECT OF HUMAN LEUKOCYTE INTERFERON IN NON-HODGKINS LYMPHOMA
Merigan, T. C., Sikora, K., BREEDEN, J. H., Levy, R., & Rosenberg, S. A. (1978). PRELIMINARY-OBSERVATIONS ON EFFECT OF HUMAN LEUKOCYTE INTERFERON IN NON-HODGKINS LYMPHOMA. NEW ENGLAND JOURNAL OF MEDICINE, 299(26), 1449–1453.

THE POTENTIAL BENEFITS OF THERAPEUTIC SPLENECTOMY FOR PATIENTS WITH HODGKINS-DISEASE AND NON-HODGKINS LYMPHOMAS
Schreiber, D. P., Jacobs, C., Rosenberg, S. A., Cox, R. S., & Hoppe, R. T. (1985). THE POTENTIAL BENEFITS OF THERAPEUTIC SPLENECTOMY FOR PATIENTS WITH HODGKINS-DISEASE AND NON-HODGKINS LYMPHOMAS. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 11(1), 31–36.

HUMAN INTERFERON ALPHA IN MALIGNANT-LYMPHOMA AND HODGKINS-DISEASE - RESULTS OF THE AMERICAN CANCER SOCIETY TRIAL
Horning, S. J., Merigan, T. C., Krown, S. E., GUTTERMAN, J. U., Louie, A., Gallagher, J., … Rosenberg, S. A. (1985). HUMAN INTERFERON ALPHA IN MALIGNANT-LYMPHOMA AND HODGKINS-DISEASE - RESULTS OF THE AMERICAN CANCER SOCIETY TRIAL. CANCER, 56(6), 1305–1310.

FOLLOW-UP OBSERVATIONS ON THE EFFECT OF HUMAN-LEUKOCYTE INTERFERON IN NON-HODGKINS LYMPHOMA
Louie, A. C., Gallagher, J. G., Sikora, K., Levy, R., Rosenberg, S. A., & Merigan, T. C. (1981). FOLLOW-UP OBSERVATIONS ON THE EFFECT OF HUMAN-LEUKOCYTE INTERFERON IN NON-HODGKINS LYMPHOMA. BLOOD, 58(4), 712–718.

CLINICAL AND IMMUNOLOGICAL EFFECTS OF RECOMBINANT LEUKOCYTE A INTERFERON IN 8 PATIENTS WITH ADVANCED CANCER
Horning, S. J., Levine, J. F., MILLER, R. A., Rosenberg, S. A., & Merigan, T. C. (1982). CLINICAL AND IMMUNOLOGICAL EFFECTS OF RECOMBINANT LEUKOCYTE A INTERFERON IN 8 PATIENTS WITH ADVANCED CANCER. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 247(12), 1718–1722.

PHASE-I STUDY OF HUMAN-LEUKOCYTE INTERFERON IN PATIENTS WITH ADVANCED CANCER
Horning, S. J., Levine, J. F., Meyer, M., Merigan, T. C., & Rosenberg, S. A. (1983). PHASE-I STUDY OF HUMAN-LEUKOCYTE INTERFERON IN PATIENTS WITH ADVANCED CANCER. JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS, 2(1), 47–56.

BRIEF CHEMOTHERAPY, STANFORD-V, AND ADJUVANT RADIOTHERAPY FOR BULKY OR ADVANCED-STAGE HODGKINS-DISEASE - A PRELIMINARY-REPORT
Bartlett, N. L., Rosenberg, S. A., Hoppe, R. T., Hancock, S. L., & Horning, S. J. (1995). BRIEF CHEMOTHERAPY, STANFORD-V, AND ADJUVANT RADIOTHERAPY FOR BULKY OR ADVANCED-STAGE HODGKINS-DISEASE - A PRELIMINARY-REPORT. JOURNAL OF CLINICAL ONCOLOGY, 13(5), 1080–88.

Modern combined modality management of Hodgkin's disease.
Rosenberg, S. A. (1994). Modern combined modality management of Hodgkin's disease. Current Opinion in Oncology, 6(5), 470–472.

CLASSIFICATION OF LYMPHOID NEOPLASMS
Rosenberg, S. A. (1994). CLASSIFICATION OF LYMPHOID NEOPLASMS. BLOOD, 84(5), 1359–1360.

The treatment of Hodgkin's disease.
Rosenberg, S. A. (1994). The treatment of Hodgkin's disease. Annals of Oncology , 5, 17–21.

Brief chemotherapy (Stanford V) and adjuvant radiotherapy for bulky or advanced Hodgkin's disease: An update
Horning, S. J., Rosenberg, S. A., & Hoppe, R. T. (1996). Brief chemotherapy (Stanford V) and adjuvant radiotherapy for bulky or advanced Hodgkin's disease: An update. Presented at the 3rd International Symposium on Hodgkins Lymphoma, COLOGNE,GERMANY: KLUWER ACADEMIC PUBL.

The management of Hodgkin's disease: Half a century of change - The Kaplan Memorial Lecture
Rosenberg, S. A. (1996). The management of Hodgkin's disease: Half a century of change - The Kaplan Memorial Lecture. ANNALS OF ONCOLOGY, 7(6), 555–560.

Comparison between conventional salvage therapy and high-dose therapy with autografting for recurrent or refractory Hodgkin's disease
Yuen, A. R., Rosenberg, S. A., Hoppe, R. T., HALPERN, J. D., & Horning, S. J. (1997). Comparison between conventional salvage therapy and high-dose therapy with autografting for recurrent or refractory Hodgkin's disease. BLOOD, 89(3), 814–822.

Stanford-Kaiser permanente G1 study for clinical stage I to IIA Hodgkin's disease: Subtotal lymphoid irradiation versus vinblastine, methotrexate, and bleomycin chemotherapy and regional irradiation
Horning, S. J., Hoppe, R. T., Mason, J., Brown, B. W., Hancock, S. L., Baer, D., & Rosenberg, S. A. (1997). Stanford-Kaiser permanente G1 study for clinical stage I to IIA Hodgkin's disease: Subtotal lymphoid irradiation versus vinblastine, methotrexate, and bleomycin chemotherapy and regional irradiation. JOURNAL OF CLINICAL ONCOLOGY, 15(5), 1736–44.

Closing the gap: A comparison of observed versus expected survival in follicular lymphoma (FL) at Stanford University from 1960-2003
Tan, D., Rosenberg, S. A., Lavori, P., Sigal, B. M., Levy, R., Hoppe, R. T., … Horning, S. J. (2008). Closing the gap: A comparison of observed versus expected survival in follicular lymphoma (FL) at Stanford University from 1960-2003. JOURNAL OF CLINICAL ONCOLOGY, 26(15).

Classical Hodgkin Lymphoma in First Complete Remission: Is There a Role for F-18 FDG PET/CT Surveillance?
Lagaru, A., Maeda, L. S., Lin, F. I., Hoppe, R. T., Rosenberg, S. A., Gambhir, S. S., & Advani, R. H. (2010). Classical Hodgkin Lymphoma in First Complete Remission: Is There a Role for F-18 FDG PET/CT Surveillance? Presented at the 23rd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), VIENNA,AUSTRIA,AUSTRIA,AUSTRIA,AUSTRIA,AUSTRIA,AUSTRIA,AUSTRIA,AUSTRIA,AUSTRIA: SPRINGER.

Survival in follicular lymphoma: The Stanford experience, 1960-2003.
Tan, D., Rosenberg, S. A., Levy, R., Lavori, P., Tibshirani, R., Hoppe, R. T., … Horning, S. J. (2007). Survival in follicular lymphoma: The Stanford experience, 1960-2003. BLOOD, 110(11), 1005A–1005A.

Improved prognosis after histologic transformation (HT) of follicular lymphoma (FL): The Stanford experience 1960-2003
Tan, D., Rosenberg, S. A., Lavori, P., Levy, R., Hoppe, R., Warnke, R., … Horning, S. J. (2008). Improved prognosis after histologic transformation (HT) of follicular lymphoma (FL): The Stanford experience 1960-2003. Presented at the 10th International Conference on Malignant Lymphoma, LUGANO,SWITZERLAND,SWITZERLAND,SWITZERLAND,SWITZERLAND,SWITZERLAND,SWITZERLAND,SWITZERLAND,SWITZERLAND,SWITZERLAND,SWITZERLAND,SWITZERLAND: OXFORD UNIV PRESS.

Assessment of favorable (F) versus unfavorable (U) early stage Hodgkin's disease (HD); the Stanford V plus radiotherapy (RT) experience.
Advani, R., Maeda, L., Hoppe, R. T., Breslin, S., Rosenberg, S. A., Baer, D., … Horning, S. J. (2005). Assessment of favorable (F) versus unfavorable (U) early stage Hodgkin's disease (HD); the Stanford V plus radiotherapy (RT) experience. BLOOD, 106(11), 548A–548A.

PET status after Stanford V chemotherapy predicts outcome in Hodgkins disease
Advani, R., Maeda, L., Lavori, P., Hoppe, R., Breslin, S., Rosenberg, S., & Horning, S. (2005). PET status after Stanford V chemotherapy predicts outcome in Hodgkins disease. Presented at the 9th International Conference on Malignant Lymphoma, LUGANO,SWITZERLAND,SWITZERLAND,SWITZERLAND,SWITZERLAND,SWITZERLAND,SWITZERLAND,SWITZERLAND,SWITZERLAND: OXFORD UNIV PRESS.

Role or FDG-PET/CT Surveillance for Patients with Classical Hodgkin's Disease in First Complete Response: The Stanford University Experience.
Maeda, L. S., Horning, S. J., Iagaru, A. H., Lin, F. I., Hoppe, R. T., Rosenberg, S. A., & Advani, R. H. (2009). Role or FDG-PET/CT Surveillance for Patients with Classical Hodgkin's Disease in First Complete Response: The Stanford University Experience. BLOOD, 114(22), 626–26.

Mid-treatment Metabolic Tumor Volume Predicts Progression and Death among Patients with Hodgkin's Disease
Tseng, D., Rachakonda, L. P., Su, Z., Advani, R., Horning, S., Rosenberg, S. A., … Tran, P. T. (2010). Mid-treatment Metabolic Tumor Volume Predicts Progression and Death among Patients with Hodgkin's Disease. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 78(3), S546–S547.

THE UTILITY OF INVASIVE DIAGNOSTIC PROCEDURES IN PATIENTS WITH LYMPHOMA WHO DEVELOP PULMONARY-INFILTRATES
Mark, J., WITTLINGER, P., Torti, F. M., Burr, D., Cohen, J., & Rosenberg, S. A. (1981). THE UTILITY OF INVASIVE DIAGNOSTIC PROCEDURES IN PATIENTS WITH LYMPHOMA WHO DEVELOP PULMONARY-INFILTRATES. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 22(MAR), 519–519.

PREGNANCY AND HODGKINS-DISEASE
Jacobs, C., Donaldson, S. S., Rosenberg, S. A., & KAPLAN, H. S. (1982). PREGNANCY AND HODGKINS-DISEASE. ANNALS OF INTERNAL MEDICINE, 96(4), 532–532.

HODGKINS-DISEASE AND THE PREGNANT PATIENT - RESPONSE
Jacobs, C., Donaldson, S. S., Rosenberg, S. A., & KAPLAN, H. S. (1982). HODGKINS-DISEASE AND THE PREGNANT PATIENT - RESPONSE. ANNALS OF INTERNAL MEDICINE, 96(5), 682–682.

OVERVIEW OF NON-HODGKINS LYMPHOMAS
DeVita, V. T., Levy, Frei, E., Royston, I., Seligmann, M., Sullivan, P., … Rosenberg, S. A. (1977). OVERVIEW OF NON-HODGKINS LYMPHOMAS. CANCER TREATMENT REPORTS, 61(6), 1219–1221.

RADIOTHERAPY WITH CURATIVE INTENT - AN OPTION IN SELECTED PATIENTS RELAPSING AFTER CHEMOTHERAPY FOR ADVANCED HODGKINS-DISEASE
Roach, M., Kapp, D. S., Rosenberg, S. A., & Hoppe, R. T. (1987). RADIOTHERAPY WITH CURATIVE INTENT - AN OPTION IN SELECTED PATIENTS RELAPSING AFTER CHEMOTHERAPY FOR ADVANCED HODGKINS-DISEASE. JOURNAL OF CLINICAL ONCOLOGY, 5(4), 550–555.

TREATMENT OF REFRACTORY NON-HODGKINS-LYMPHOMAS OF UNFAVORABLE HISTOLOGY WITH TENIPOSIDE, CYTARABINE, AND CISPLATIN
Tseng, A., Jacobs, C., Coleman, C. N., Horning, S. J., Lewis, B. J., & Rosenberg, S. A. (1987). TREATMENT OF REFRACTORY NON-HODGKINS-LYMPHOMAS OF UNFAVORABLE HISTOLOGY WITH TENIPOSIDE, CYTARABINE, AND CISPLATIN. CANCER TREATMENT REPORTS, 71(6), 659–660.

CUTANEOUS MALIGNANT-MELANOMA (CMM) FOLLOWING HODGKINS-DISEASE (HD)
TUCKER, M. A., MISFELDT, D., Coleman, C. N., Clark, W. H., Rosenberg, S. A., & KAPLAN, H. S. (1984). CUTANEOUS MALIGNANT-MELANOMA (CMM) FOLLOWING HODGKINS-DISEASE (HD). PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 25(MAR), 223–223.

ADULT LYMPHOBLASTIC LYMPHOMA-RESULTS OF A PILOT THERAPY PROTOCOL
Coleman, C. N., Cohen, J. R., & Rosenberg, S. A. (1980). ADULT LYMPHOBLASTIC LYMPHOMA-RESULTS OF A PILOT THERAPY PROTOCOL. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 21(MAR), 466–466.

HODGKINS-DISEASE (HD), PATHOLOGIC STAGE (PS) I-II - THE PROGNOSTIC IMPORTANCE OF INITIAL SITES OF DISEASE AND EXTENT OF MEDIASTINAL (MED) INVOLVEMENT
Hoppe, R. T., Coleman, C. N., KAPLAN, H. S., & Rosenberg, S. A. (1980). HODGKINS-DISEASE (HD), PATHOLOGIC STAGE (PS) I-II - THE PROGNOSTIC IMPORTANCE OF INITIAL SITES OF DISEASE AND EXTENT OF MEDIASTINAL (MED) INVOLVEMENT. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 21(MAR), 471–471.

2ND CANCERS AFTER RADIOTHERAPY FOR HODGKINS-DISEASE - REPLY
TUCKER, M. A., Coleman, C. N., & Rosenberg, S. A. (1988). 2ND CANCERS AFTER RADIOTHERAPY FOR HODGKINS-DISEASE - REPLY. NEW ENGLAND JOURNAL OF MEDICINE, 319(4), 245–246.

Efficacy and late effects of Stanford V chemotherapy and radiotherapy in untreated Hodgkin's disease: Mature data in early and advanced stage patients.
Horning, S. J., Hoppe, R. T., Advani, R., Warnke, R., Baer, D., Mason, J., & Rosenberg, S. A. (2004). Efficacy and late effects of Stanford V chemotherapy and radiotherapy in untreated Hodgkin's disease: Mature data in early and advanced stage patients. BLOOD, 104(11), 92A–92A.

Very brief (8 week) chemotherapy (CT) and low dose (30 Gy) radiotherapy (RT) for limited stage Hodgkin's disease (HD): Preliminary results of the Stanford-Kaiser G4 study of Stanford V plus RT.
Horning, S. J., Hoppe, R. T., Breslin, S., Baer, D. M., Mason, J., & Rosenberg, S. A. (1999). Very brief (8 week) chemotherapy (CT) and low dose (30 Gy) radiotherapy (RT) for limited stage Hodgkin's disease (HD): Preliminary results of the Stanford-Kaiser G4 study of Stanford V plus RT. BLOOD, 94(10), 387A–387A.

CHEMOTHERAPY OF NON-HODGKINS LYMPHOMAS
Frei, E., ANDERSON, T., Bertino, J. R., Bloomfield, C. D., Richardson, Coltman, C. A., … Johnston. (1977). CHEMOTHERAPY OF NON-HODGKINS LYMPHOMAS. CANCER TREATMENT REPORTS, 61(6), 1125–1127.

LYMPHOBLASTIC LYMPHOMA IN ADULTS - RESULTS OF A PILOT PROTOCOL
Coleman, C. N., Cohen, J. R., Burke, J. S., & Rosenberg, S. A. (1981). LYMPHOBLASTIC LYMPHOMA IN ADULTS - RESULTS OF A PILOT PROTOCOL. BLOOD, 57(4), 679–684.

Improvements in observed and relative survival in follicular grade 1-2 lymphoma during 4 decades: the Stanford University experience.
Tan, D., Horning, S. J., Hoppe, R. T., Levy, R., Rosenberg, S. A., Sigal, B. M., … Advani, R. H. (2013). Improvements in observed and relative survival in follicular grade 1-2 lymphoma during 4 decades: the Stanford University experience. Blood, 122(6), 981–87.

12-WEEKS OF CHEMOTHERAPY AND INVOLVED FIELD RADIOTHERAPY (RT) ARE HIGHLY EFFECTIVE FOR UNFAVORABLE HODGKINS-DISEASE (HD) - THE STANFORD V REGIMEN
Barlett, N. L., Rosenberg, S. A., Hoppe, R. T., & Horning, S. J. (1993). 12-WEEKS OF CHEMOTHERAPY AND INVOLVED FIELD RADIOTHERAPY (RT) ARE HIGHLY EFFECTIVE FOR UNFAVORABLE HODGKINS-DISEASE (HD) - THE STANFORD V REGIMEN. BLOOD, 82(10), A333–A333.

COMPARISON BETWEEN AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) AND CONVENTIONAL SALVAGE THERAPY FOR RECURRENT OR REFRACTORY HODGKINS-DISEASE
Yuen, A. R., Blume, K. G., Rosenberg, S. A., Hoppe, R. T., Chao, N. J., Negrin, R. S., … Horning, S. J. (1994). COMPARISON BETWEEN AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) AND CONVENTIONAL SALVAGE THERAPY FOR RECURRENT OR REFRACTORY HODGKINS-DISEASE. BLOOD, 84(10), A234–A234.

Stage I/II Hodgkin's disease (HD) with bulky mediastinal disease or other risk factors (RF) the Stanford V experience
Advani, R. H., Hoppe, R. T., Rosenberg, S. A., & Horning, S. J. (2007). Stage I/II Hodgkin's disease (HD) with bulky mediastinal disease or other risk factors (RF) the Stanford V experience. Presented at the 7th International Symposium on Hodgkins Lymphoma, COLOGNE,GERMANY,GERMANY,GERMANY,GERMANY,GERMANY,GERMANY,GERMANY,GERMANY: FERRATA STORTI FOUNDATION.

Attitudes and beliefs towards surviorship issues in Hodgkin's disease (HD). Results of focus group discussions with patients treated at stanford university
Advani, R., Rosenberg, S., Talreja, N., Hoppe, R., & Horning, S. (2008). Attitudes and beliefs towards surviorship issues in Hodgkin's disease (HD). Results of focus group discussions with patients treated at stanford university. Presented at the 10th International Conference on Malignant Lymphoma, LUGANO,SWITZERLAND,SWITZERLAND,SWITZERLAND,SWITZERLAND,SWITZERLAND,SWITZERLAND,SWITZERLAND,SWITZERLAND: OXFORD UNIV PRESS.

THE TREATMENT OF HODGKINS-DISEASE
Rosenberg, S. A. (1994). THE TREATMENT OF HODGKINS-DISEASE. ANNALS OF ONCOLOGY, 5, S17–S21.

PROGNOSTIC FACTORS IN ADVANCED HISTIOCYTIC LYMPHOMA
MacKintosh, F. R., ONEIL, M., & Rosenberg, S. A. (1980). PROGNOSTIC FACTORS IN ADVANCED HISTIOCYTIC LYMPHOMA. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 21(MAR), 465–465.

A prospective trial of involved field radiation (IFRT) plus chemotherapy vs extended field (EFRT) radiation for favorable Hodgkin's disease (HD): Long-term follow-up and implications for current combined modality therapy
Horning, S. J., Hoppe, R. T., Advani, R. H., Breslin, S., McCormick, E., Allen, J., … Rosenberg, S. A. (2007). A prospective trial of involved field radiation (IFRT) plus chemotherapy vs extended field (EFRT) radiation for favorable Hodgkin's disease (HD): Long-term follow-up and implications for current combined modality therapy. Presented at the 7th International Symposium on Hodgkins Lymphoma, COLOGNE,GERMANY,GERMANY,GERMANY,GERMANY,GERMANY,GERMANY,GERMANY,GERMANY,GERMANY,GERMANY: FERRATA STORTI FOUNDATION.

Stage I/II Hodgkin's disease: Comparison of outcomes of patients with bulky mediastinal disease versus other risk factors; the Stanford V experience
Advani, R. H., Hoppe, R. T., Rosenberg, S. A., & Horning, S. J. (2007). Stage I/II Hodgkin's disease: Comparison of outcomes of patients with bulky mediastinal disease versus other risk factors; the Stanford V experience. BLOOD, 110(11), 685A–685A.

Efficacy of Abbreviated Stanford V Chemotherapy and Involved Field Radiotherapy in Early Stage Hodgkin's Disease: Mature Results of the G4 Trial.
Advani, R. H., Hoppe, R. T., Baer, D. M., Mason, J., Rosenberg, S. A., & Horning, S. J. (2009). Efficacy of Abbreviated Stanford V Chemotherapy and Involved Field Radiotherapy in Early Stage Hodgkin's Disease: Mature Results of the G4 Trial. BLOOD, 114(22), 666–67.

DEATHS AFTER TREATMENT OF HODGKIN DISEASE - CORRECTION
Hancock, S. L., Cox, R. S., & Rosenberg, S. A. (1991). DEATHS AFTER TREATMENT OF HODGKIN DISEASE - CORRECTION. ANNALS OF INTERNAL MEDICINE, 114(9), 810–810.

High dose therapy and autografting for follicular low grade lymphoma in first remission: The Stanford experience.
Horning, S. J., Negrin, R. S., Hoppe, R. T., Chao, N. J., Long, G. D., Rosenberg, S. A., … Blume, K. G. (1997). High dose therapy and autografting for follicular low grade lymphoma in first remission: The Stanford experience. BLOOD, 90(10), 2641–2641.

COMBINATION CHEMOTHERAPY IN HODGKINS-DISEASE - RELATION TO RADIOTHERAPY
Rosenberg, S. A. (1973). COMBINATION CHEMOTHERAPY IN HODGKINS-DISEASE - RELATION TO RADIOTHERAPY. BIBLIOTHECA HAEMATOLOGICA, (40), 731–735.

THE RELATIVE CLINICAL-VALUE OF THE VARIOUS CLASSIFICATIONS OF HUMAN NON-HODGKINS LYMPHOMAS
Rosenberg, S. A. (1982). THE RELATIVE CLINICAL-VALUE OF THE VARIOUS CLASSIFICATIONS OF HUMAN NON-HODGKINS LYMPHOMAS. UCLA SYMPOSIA ON MOLECULAR AND CELLULAR BIOLOGY, 24, 43–50.

Dynamic CD8 T-cell responses to tumor-associated Epstein-Barr virus (EBV) antigens in patients with EBV-negative Hodgkin's disease
Kohrt, H. E., Advani, R., Hoppe, R., Rosenberg, S., Horning, S., & Lee, P. P. (2009). Dynamic CD8 T-cell responses to tumor-associated Epstein-Barr virus (EBV) antigens in patients with EBV-negative Hodgkin's disease. JOURNAL OF CLINICAL ONCOLOGY, 27(15).

NON-HODGKINS LYMPHOMA - SELECTION OF TREATMENT ON THE BASIS OF HISTOLOGIC TYPE
Rosenberg, S. A. (1979). NON-HODGKINS LYMPHOMA - SELECTION OF TREATMENT ON THE BASIS OF HISTOLOGIC TYPE. NEW ENGLAND JOURNAL OF MEDICINE, 301(17), 924–928.

Update on a comparison between conventional salvage therapy and high-dose therapy with autografting for recurrent or refractory Hodgkin's disease.
Yuen, A. R., Blume, K. G., Rosenberg, S. A., Hoppe, R. T., Chao, N. J., Long, G. D., & Horning, S. J. (2001). Update on a comparison between conventional salvage therapy and high-dose therapy with autografting for recurrent or refractory Hodgkin's disease. BLOOD, 98(11), 401B–401B.

AN EVALUATION OF ABDOMINAL CT SCANNING IN INITIAL STAGING OF HODGKINS AND NON-HODGKINS LYMPHOMA - PROGRESS REPORT
Castellino, R. A., NOON, M., Young, S., Blank, N., Hoppe, R., Rosenberg, S., & KAPLAN, H. S. (1981). AN EVALUATION OF ABDOMINAL CT SCANNING IN INITIAL STAGING OF HODGKINS AND NON-HODGKINS LYMPHOMA - PROGRESS REPORT. INVESTIGATIVE RADIOLOGY, 16(5), 415–415.

FEMALE AND MALE-FERTILITY AFTER COMBINED MODALITY THERAPY FOR HODGKINS-DISEASE
Horning, S. J., Hoppe, R. T., KAPLAN, H. S., & Rosenberg, S. A. (1981). FEMALE AND MALE-FERTILITY AFTER COMBINED MODALITY THERAPY FOR HODGKINS-DISEASE. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 22(MAR), 512–512.

KARNOFSKY MEMORIAL LECTURE - THE LOW-GRADE NON-HODGKINS LYMPHOMAS - CHALLENGES AND OPPORTUNITIES
Rosenberg, S. A. (1985). KARNOFSKY MEMORIAL LECTURE - THE LOW-GRADE NON-HODGKINS LYMPHOMAS - CHALLENGES AND OPPORTUNITIES. JOURNAL OF CLINICAL ONCOLOGY, 3(3), 298–310.

SUMMARY OF RESULTS OF A REVIEW OF 405 PATIENTS WITH NON-HODGKINS LYMPHOMA AT STANFORD-UNIVERSITY
Rosenberg, S. A., Dorfman, R. F., & KAPLAN, H. S. (1975). SUMMARY OF RESULTS OF A REVIEW OF 405 PATIENTS WITH NON-HODGKINS LYMPHOMA AT STANFORD-UNIVERSITY. BRITISH JOURNAL OF CANCER, 31, 168–173.

PROGNOSTIC FACTORS AFTER RELAPSE IN NON-HODGKINS LYMPHOMA OF FAVORABLE HISTOLOGIC TYPE
ACKER, B. D., Hoppe, R. T., Rosenberg, S. A., & KAPLAN, H. S. (1980). PROGNOSTIC FACTORS AFTER RELAPSE IN NON-HODGKINS LYMPHOMA OF FAVORABLE HISTOLOGIC TYPE. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 6(10), 1349–1349.

NATIONAL-CANCER-INSTITUTE SPONSORED STUDY OF CLASSIFICATIONS OF NON-HODGKINS LYMPHOMAS - SUMMARY AND DESCRIPTION OF A WORKING FORMULATION FOR CLINICAL USAGE
Rosenberg, S. A. (1982). NATIONAL-CANCER-INSTITUTE SPONSORED STUDY OF CLASSIFICATIONS OF NON-HODGKINS LYMPHOMAS - SUMMARY AND DESCRIPTION OF A WORKING FORMULATION FOR CLINICAL USAGE. CANCER, 49(10), 2112–2135.

VALUE OF SEQUENTIAL BONE-MARROW BIOPSY AND LAPAROTOMY AND SPLENECTOMY IN A SERIES OF 127 CONSECUTIVE UNTREATED PATIENTS WITH NON-HODGKINS LYMPHOMA
Rosenberg, S. A., Dorfman, R. F., & KAPLAN, H. S. (1975). VALUE OF SEQUENTIAL BONE-MARROW BIOPSY AND LAPAROTOMY AND SPLENECTOMY IN A SERIES OF 127 CONSECUTIVE UNTREATED PATIENTS WITH NON-HODGKINS LYMPHOMA. BRITISH JOURNAL OF CANCER, 31, 221–227.

Incidence of secondary leukemia/myelodysplasia (AML/MDS) in Hodgkin's disease (HD) with three generations of therapy at Stanford University.
Advani, R. H., Hoppe, R. T., Rosenberg, S. A., & Horning, S. J. (2006). Incidence of secondary leukemia/myelodysplasia (AML/MDS) in Hodgkin's disease (HD) with three generations of therapy at Stanford University. JOURNAL OF CLINICAL ONCOLOGY, 24(18), 426S–426S.

PROGNOSTIC FACTORS IN PATHOLOGIC STAGE (PS) IIIA HODGKINS-DISEASE (HD)
Hoppe, R. T., Cox, R. S., Rosenberg, S. A., & KAPLAN, H. S. (1979). PROGNOSTIC FACTORS IN PATHOLOGIC STAGE (PS) IIIA HODGKINS-DISEASE (HD). PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 20(MAR), 429–429.

BONE-MARROW INVOLVEMENT IN NON-HODGKINS LYMPHOMATA
Rosenberg, S. A. (1975). BONE-MARROW INVOLVEMENT IN NON-HODGKINS LYMPHOMATA. BRITISH JOURNAL OF CANCER, 31, 261–264.

CLINICAL TRIALS IN NON-HODGKINS LYMPHOMATA AT STANFORD-UNIVERSITY EXPERIMENTAL DESIGN AND PRELIMINARY RESULTS
Rosenberg, S. A., & KAPLAN, H. S. (1975). CLINICAL TRIALS IN NON-HODGKINS LYMPHOMATA AT STANFORD-UNIVERSITY EXPERIMENTAL DESIGN AND PRELIMINARY RESULTS. BRITISH JOURNAL OF CANCER, 31, 456–464.

SINGLE AGENT PALLIATIVE CHEMOTHERAPY FOR END-STAGE HODGKINS-DISEASE
Mead, G. M., Harker, W. G., KUSHLAN, P., & Rosenberg, S. A. (1982). SINGLE AGENT PALLIATIVE CHEMOTHERAPY FOR END-STAGE HODGKINS-DISEASE. CANCER, 50(5), 829–835.

THE TREATMENT OF ADVANCED STAGE FAVORABLE HISTOLOGY NON-HODGKINS LYMPHOMA - A PRELIMINARY-REPORT OF A RANDOMIZED TRIAL COMPARING SINGLE AGENT CHEMOTHERAPY, COMBINATION CHEMOTHERAPY, AND WHOLE-BODY IRRADIATION
Hoppe, R. T., KUSHLAN, P., KAPLAN, H. S., Rosenberg, S. A., & Brown, B. W. (1981). THE TREATMENT OF ADVANCED STAGE FAVORABLE HISTOLOGY NON-HODGKINS LYMPHOMA - A PRELIMINARY-REPORT OF A RANDOMIZED TRIAL COMPARING SINGLE AGENT CHEMOTHERAPY, COMBINATION CHEMOTHERAPY, AND WHOLE-BODY IRRADIATION. BLOOD, 58(3), 592–598.

CLINICAL ASPECTS OF NON-HODGKINS LYMPHOMAS PRESENTING WITH DISCORDANT HISTOLOGIC SUBTYPES
Mead, G. M., KUSHLAN, P., ONEIL, M., Burke, J. S., & Rosenberg, S. A. (1983). CLINICAL ASPECTS OF NON-HODGKINS LYMPHOMAS PRESENTING WITH DISCORDANT HISTOLOGIC SUBTYPES. CANCER, 52(8), 1496–1501.

COMBINATION CHEMOTHERAPY FOR ADVANCED HODGKINS-DISEASE AFTER FAILURE OF MOPP - ABVD AND B-CAVE
Harker, W. G., KUSHLAN, P., & Rosenberg, S. A. (1984). COMBINATION CHEMOTHERAPY FOR ADVANCED HODGKINS-DISEASE AFTER FAILURE OF MOPP - ABVD AND B-CAVE. ANNALS OF INTERNAL MEDICINE, 101(4), 440–446.

HODGKINS-DISEASE - NO STAGE BEYOND CURE
Rosenberg, S. A. (1986). HODGKINS-DISEASE - NO STAGE BEYOND CURE. HOSPITAL PRACTICE, 21(8), 91-?

HODGKINS-DISEASE - CURRENT STATUS AND FUTURE CHALLENGES
Rosenberg, S. A. (1980). HODGKINS-DISEASE - CURRENT STATUS AND FUTURE CHALLENGES. SEMINARS IN ONCOLOGY, 7(2), 212–214.

MANAGEMENT OF HODGKINS-DISEASE
KAPLAN, H. S., & Rosenberg, S. A. (1975). MANAGEMENT OF HODGKINS-DISEASE. CANCER, 36(2), 796–803.

PREDICTIVE VALUE OF LYMPHOGRAPHY FOR SITES OF SUBDIAPHRAGMATIC DISEASE ENCOUNTERED AT STAGING LAPAROTOMY IN NEWLY DIAGNOSED HODGKINS-DISEASE AND NON-HODGKINS LYMPHOMA
Castellino, R. A., Dunnick, N. R., Goffinet, D. R., ROSENBERG, S. R., & KAPLAN, H. S. (1983). PREDICTIVE VALUE OF LYMPHOGRAPHY FOR SITES OF SUBDIAPHRAGMATIC DISEASE ENCOUNTERED AT STAGING LAPAROTOMY IN NEWLY DIAGNOSED HODGKINS-DISEASE AND NON-HODGKINS LYMPHOMA. JOURNAL OF CLINICAL ONCOLOGY, 1(9), 532–536.

CHEMOTHERAPY OF NON-HODGKINS LYMPHOMAS - STANFORD EXPERIENCE
Portlock, C. S., & Rosenberg, S. A. (1977). CHEMOTHERAPY OF NON-HODGKINS LYMPHOMAS - STANFORD EXPERIENCE. CANCER TREATMENT REPORTS, 61(6), 1049–1055.

VALUE OF SEQUENTIAL BONE-MARROW BIOPSY AND LAPAROTOMY AND SPLENECTOMY IN A SERIES OF 200 CONSECUTIVE UNTREATED PATIENTS WITH NON-HODGKINS LYMPHOMA
RIBASMUNDO, M., & Rosenberg, S. A. (1979). VALUE OF SEQUENTIAL BONE-MARROW BIOPSY AND LAPAROTOMY AND SPLENECTOMY IN A SERIES OF 200 CONSECUTIVE UNTREATED PATIENTS WITH NON-HODGKINS LYMPHOMA. EUROPEAN JOURNAL OF CANCER, 15(7), 941–952.

THE CONCEPT, EVOLUTION AND PRELIMINARY-RESULTS OF THE CURRENT STANFORD CLINICAL-TRIALS FOR HODGKINS-DISEASE
Hoppe, R. T., Horning, S. J., & Rosenberg, S. A. (1985). THE CONCEPT, EVOLUTION AND PRELIMINARY-RESULTS OF THE CURRENT STANFORD CLINICAL-TRIALS FOR HODGKINS-DISEASE. CANCER SURVEYS, 4(2), 459–475.

INITIAL RELAPSE IN PREVIOUSLY TREATED HODGKINS-DISEASE .2. RETROGRADE TRANS-DIAPHRAGMATIC EXTENSION
Weller, S. A., Glatstein, E., Castellino, R. A., KAPLAN, H. S., & Rosenberg, S. A. (1977). INITIAL RELAPSE IN PREVIOUSLY TREATED HODGKINS-DISEASE .2. RETROGRADE TRANS-DIAPHRAGMATIC EXTENSION. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2(9-10), 863–872.

VALIDITY OF ANN-ARBOR STAGING CLASSIFICATION FOR NON-HODGKINS LYMPHOMAS
Rosenberg, S. A. (1977). VALIDITY OF ANN-ARBOR STAGING CLASSIFICATION FOR NON-HODGKINS LYMPHOMAS. CANCER TREATMENT REPORTS, 61(6), 1023–1027.

PROGNOSTIC FACTORS IN PATHOLOGIC STAGE-III HODGKINS-DISEASE
Hoppe, R. T., Cox, R. S., Rosenberg, S. A., & KAPLAN, H. S. (1982). PROGNOSTIC FACTORS IN PATHOLOGIC STAGE-III HODGKINS-DISEASE. CANCER TREATMENT REPORTS, 66(4), 743–749.

IMPACT OF SALVAGE TREATMENT ON INITIAL RELAPSES IN PATIENTS WITH HODGKIN DISEASE, STAGES I-III
Portlock, C. S., Rosenberg, S. A., Glatstein, E., & KAPLAN, H. S. (1978). IMPACT OF SALVAGE TREATMENT ON INITIAL RELAPSES IN PATIENTS WITH HODGKIN DISEASE, STAGES I-III. BLOOD, 51(5), 825–833.

ALTERNATING CHEMOTHERAPY AND IRRADIATION IN THE TREATMENT OF ADVANCED HODGKINS-DISEASE
Hoppe, R. T., Portlock, C. S., Glatstein, E., Rosenberg, S. A., & KAPLAN, H. S. (1979). ALTERNATING CHEMOTHERAPY AND IRRADIATION IN THE TREATMENT OF ADVANCED HODGKINS-DISEASE. CANCER, 43(2), 472–481.

COMPUTED-TOMOGRAPHY, LYMPHOGRAPHY, AND STAGING LAPAROTOMY - CORRELATIONS IN INITIAL STAGING OF HODGKIN DISEASE
Castellino, R. A., Hoppe, R. T., Blank, N., Young, S. W., Neumann, C., Rosenberg, S. A., & KAPLAN, H. S. (1984). COMPUTED-TOMOGRAPHY, LYMPHOGRAPHY, AND STAGING LAPAROTOMY - CORRELATIONS IN INITIAL STAGING OF HODGKIN DISEASE. AMERICAN JOURNAL OF ROENTGENOLOGY, 143(1), 37–41.

THE TREATMENT OF MALIGNANT HISTIOCYTOSIS
Tseng, A., Coleman, C. N., Cox, R. S., Colby, T. V., Turner, R. R., Horning, S. J., & Rosenberg, S. A. (1984). THE TREATMENT OF MALIGNANT HISTIOCYTOSIS. BLOOD, 64(1), 48–53.

3RD-LINE CHEMOTHERAPY FOR RESISTANT HODGKINS-DISEASE WITH LOMUSTINE, ETOPOSIDE, AND METHOTREXATE
Tseng, A., Jacobs, C., Coleman, C. N., Horning, S. J., Lewis, B. J., & Rosenberg, S. A. (1987). 3RD-LINE CHEMOTHERAPY FOR RESISTANT HODGKINS-DISEASE WITH LOMUSTINE, ETOPOSIDE, AND METHOTREXATE. CANCER TREATMENT REPORTS, 71(5), 475–478.

LATE RELAPSE FROM COMPLETE REMISSION IN NODULAR AND DIFFUSE HISTIOCYTIC LYMPHOMA
Mead, G. M., MacKintosh, F. R., Burke, J. S., & Rosenberg, S. A. (1983). LATE RELAPSE FROM COMPLETE REMISSION IN NODULAR AND DIFFUSE HISTIOCYTIC LYMPHOMA. CANCER, 52(8), 1356–1359.

Histologic subtypes of breast cancer following radiotherapy for Hodgkin lymphoma.
Horst, K. C., Hancock, S. L., OGNIBENE, G., Chen, C., Advani, R. H., Rosenberg, S. A., … Hoppe, R. T. (2014). Histologic subtypes of breast cancer following radiotherapy for Hodgkin lymphoma. Annals of Oncology , 25(4), 848–51.

The Paris Conference "La Radiothérapie de la Maladie de Hodgkin": A First Step in the Cure of Hodgkin Disease.
Hoppe, R. T., & Rosenberg, S. A. (2015). The Paris Conference "La Radiothérapie de la Maladie de Hodgkin": A First Step in the Cure of Hodgkin Disease. International Journal of Radiation Oncology, Biology, Physics, 92(1), 3–4.

A CLINICAL AND EPIDEMIOLOGIC-STUDY OF HUMAN-LEUKOCYTE ANTIGEN-DPB ALLELES IN HODGKINS-DISEASE
Oza, A. M., Tonks, S., Lim, J., FLEETWOOD, M. A., Lister, T. A., Bodmer, J. G., … Harousseau, J. L. (1994). A CLINICAL AND EPIDEMIOLOGIC-STUDY OF HUMAN-LEUKOCYTE ANTIGEN-DPB ALLELES IN HODGKINS-DISEASE. CANCER RESEARCH, 54(19), 5101–5.

MANAGEMENT OF THE PREGNANT PATIENT WITH HODGKINS-DISEASE
Jacobs, C., Donaldson, S. S., Rosenberg, S. A., & KAPLAN, H. S. (1981). MANAGEMENT OF THE PREGNANT PATIENT WITH HODGKINS-DISEASE. ANNALS OF INTERNAL MEDICINE, 95(6), 669–675.

LATE RELAPSE AMONG PATIENTS TREATED FOR HODGKINS-DISEASE
Herman, T. S., Hoppe, R. T., Donaldson, S. S., Cox, R. S., Rosenberg, S. A., & KAPLAN, H. S. (1985). LATE RELAPSE AMONG PATIENTS TREATED FOR HODGKINS-DISEASE. ANNALS OF INTERNAL MEDICINE, 102(3), 292–297.

THE NATURAL-HISTORY OF INITIALLY UNTREATED LOW-GRADE NON-HODGKINS LYMPHOMAS
Horning, S. J., & Rosenberg, S. A. (1984). THE NATURAL-HISTORY OF INITIALLY UNTREATED LOW-GRADE NON-HODGKINS LYMPHOMAS. NEW ENGLAND JOURNAL OF MEDICINE, 311(23), 1471–1475.

FEMALE REPRODUCTIVE POTENTIAL AFTER TREATMENT FOR HODGKINS-DISEASE
Horning, S. J., Hoppe, R. T., KAPLAN, H. S., & Rosenberg, S. A. (1981). FEMALE REPRODUCTIVE POTENTIAL AFTER TREATMENT FOR HODGKINS-DISEASE. NEW ENGLAND JOURNAL OF MEDICINE, 304(23), 1377–1382.

SELECTION OF PATIENTS WITH HODGKINS-DISEASE AND NON-HODGKINS-LYMPHOMA FOR BONE-MARROW TRANSPLANTATION
Sullivan, K. M., Appelbaum, F. R., Horning, S. J., Rosenberg, S. A., & Thomas, E. D. (1986). SELECTION OF PATIENTS WITH HODGKINS-DISEASE AND NON-HODGKINS-LYMPHOMA FOR BONE-MARROW TRANSPLANTATION. INTERNATIONAL JOURNAL OF CELL CLONING, 4, 94–106.

OCCURRENCE OF NON-HODGKINS LYMPHOMA AFTER THERAPY FOR HODGKINS-DISEASE
KRIKORIAN, J. G., Burke, J. S., Rosenberg, S. A., & KAPLAN, H. S. (1979). OCCURRENCE OF NON-HODGKINS LYMPHOMA AFTER THERAPY FOR HODGKINS-DISEASE. NEW ENGLAND JOURNAL OF MEDICINE, 300(9), 452–458.

HISTOLOGIC CONVERSION IN THE NON-HODGKINS LYMPHOMAS
Acker, B., Hoppe, R. T., Colby, T. V., Cox, R. S., KAPLAN, H. S., & Rosenberg, S. A. (1983). HISTOLOGIC CONVERSION IN THE NON-HODGKINS LYMPHOMAS. JOURNAL OF CLINICAL ONCOLOGY, 1(1), 11–16.

COMBINED MODALITY THERAPY FOR ADULTS WITH SMALL NONCLEAVED CELL LYMPHOMA (BURKITTS AND NON-BURKITTS TYPES)
Bernstein, J. I., Coleman, C. N., Strickler, J. G., Dorfman, R. F., & Rosenberg, S. A. (1986). COMBINED MODALITY THERAPY FOR ADULTS WITH SMALL NONCLEAVED CELL LYMPHOMA (BURKITTS AND NON-BURKITTS TYPES). JOURNAL OF CLINICAL ONCOLOGY, 4(6), 847–858.

NO INITIAL THERAPY FOR STAGE-III AND STAGE-IV NON-HODGKIN LYMPHOMAS OF FAVORABLE HISTOLOGIC TYPES
Portlock, C. S., & Rosenberg, S. A. (1979). NO INITIAL THERAPY FOR STAGE-III AND STAGE-IV NON-HODGKIN LYMPHOMAS OF FAVORABLE HISTOLOGIC TYPES. ANNALS OF INTERNAL MEDICINE, 90(1), 10–13.

HODGKINS-DISEASE LIMITED TO INTRATHORACIC SITES
Johnson, D. W., Hoppe, R. T., Cox, R. S., Rosenberg, S. A., & KAPLAN, H. S. (1983). HODGKINS-DISEASE LIMITED TO INTRATHORACIC SITES. CANCER, 52(1), 8–13.

TREATMENT OF LYMPHOBLASTIC LYMPHOMA IN ADULTS
Coleman, C. N., Picozzi, V. J., Cox, R. S., MCWHIRTER, K., Weiss, L. M., Cohen, J. R., … Rosenberg, S. A. (1986). TREATMENT OF LYMPHOBLASTIC LYMPHOMA IN ADULTS. JOURNAL OF CLINICAL ONCOLOGY, 4(11), 1628–1637.

PROGNOSTIC FACTORS IN PATHOLOGICAL STAGE-IIIA HODGKINS-DISEASE
Hoppe, R. T., Rosenberg, S. A., KAPLAN, H. S., & Cox, R. S. (1980). PROGNOSTIC FACTORS IN PATHOLOGICAL STAGE-IIIA HODGKINS-DISEASE. CANCER, 46(5), 1240–1246.

EXTRALYMPHATIC INVOLVEMENT IN DIFFUSE NON-HODGKINS LYMPHOMA
Paryani, S., Hoppe, R. T., Burke, J. S., Sneed, P., Dawley, D., Cox, R. S., … KAPLAN, H. S. (1983). EXTRALYMPHATIC INVOLVEMENT IN DIFFUSE NON-HODGKINS LYMPHOMA. JOURNAL OF CLINICAL ONCOLOGY, 1(11), 682–688.

RISK OF 2ND CANCERS AFTER TREATMENT FOR HODGKINS-DISEASE
TUCKER, M. A., Coleman, C. N., Cox, R. S., Varghese, A., & Rosenberg, S. A. (1988). RISK OF 2ND CANCERS AFTER TREATMENT FOR HODGKINS-DISEASE. NEW ENGLAND JOURNAL OF MEDICINE, 318(2), 76–81.

REPORT OF A COMMITTEE CONVENED TO DISCUSS THE EVALUATION AND STAGING OF PATIENTS WITH HODGKINS-DISEASE - COTSWOLDS MEETING
Lister, T. A., Crowther, D., Sutcliffe, S. B., Glatstein, E., Canellos, G. P., Young, R. C., … Tubiana, M. (1989). REPORT OF A COMMITTEE CONVENED TO DISCUSS THE EVALUATION AND STAGING OF PATIENTS WITH HODGKINS-DISEASE - COTSWOLDS MEETING. JOURNAL OF CLINICAL ONCOLOGY, 7(11), 1630–1636.

SPONTANEOUS REGRESSION OF NON-HODGKINS LYMPHOMA - A REPORT OF 9 CASES
KRIKORIAN, J. G., Portlock, C. S., Cooney, D. P., & Rosenberg, S. A. (1980). SPONTANEOUS REGRESSION OF NON-HODGKINS LYMPHOMA - A REPORT OF 9 CASES. CANCER, 46(9), 2093–2099.

Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity
Yang, J. C., Chang, A. E., BAKER, A. R., SINDELAR, W. F., Danforth, D. N., Topalian, S. L., … Rosenberg, S. A. (1998). Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. JOURNAL OF CLINICAL ONCOLOGY, 16(1), 197–203.

HODGKINS-DISEASE, STAGE-I AND STAGE-II OCCURRING BELOW THE DIAPHRAGM
KRIKORIAN, J. G., Portlock, C. S., Rosenberg, S. A., & KAPLAN, H. S. (1979). HODGKINS-DISEASE, STAGE-I AND STAGE-II OCCURRING BELOW THE DIAPHRAGM. CANCER, 43(5), 1866–1871.

ANALYSIS OF NON-HODGKINS LYMPHOMAS WITH NODULAR AND FAVORABLE HISTOLOGIES, STAGE-I AND STAGE-II
PARYANI, S. B., Hoppe, R. T., Cox, R. S., Colby, T. V., Rosenberg, S. A., & KAPLAN, H. S. (1983). ANALYSIS OF NON-HODGKINS LYMPHOMAS WITH NODULAR AND FAVORABLE HISTOLOGIES, STAGE-I AND STAGE-II. CANCER, 52(12), 2300–2307.

SUBDIAPHRAGMATIC HODGKINS-DISEASE - LAPAROTOMY AND TREATMENT RESULTS IN 49 PATIENTS
LEIBENHAUT, M. H., Hoppe, R. T., Varghese, A., & Rosenberg, S. A. (1987). SUBDIAPHRAGMATIC HODGKINS-DISEASE - LAPAROTOMY AND TREATMENT RESULTS IN 49 PATIENTS. JOURNAL OF CLINICAL ONCOLOGY, 5(7), 1050–1055.

THE EVOLUTION AND SUMMARY RESULTS OF THE STANFORD RANDOMIZED CLINICAL-TRIALS OF THE MANAGEMENT OF HODGKINS-DISEASE - 1962-1984
Rosenberg, S. A., & KAPLAN, H. S. (1985). THE EVOLUTION AND SUMMARY RESULTS OF THE STANFORD RANDOMIZED CLINICAL-TRIALS OF THE MANAGEMENT OF HODGKINS-DISEASE - 1962-1984. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 11(1), 5–22.

EXTRA-LYMPHATIC HODGKINS-DISEASE - PROGNOSIS AND RESPONSE TO THERAPY
Torti, F. M., Portlock, C. S., Rosenberg, S. A., & KAPLAN, H. S. (1981). EXTRA-LYMPHATIC HODGKINS-DISEASE - PROGNOSIS AND RESPONSE TO THERAPY. AMERICAN JOURNAL OF MEDICINE, 70(3), 487–492.

HODGKINS-DISEASE IN PATIENTS OVER 60 YEARS OLD
AUSTINSEYMOUR, M. M., Hoppe, R. T., Cox, R. S., Rosenberg, S. A., & KAPLAN, H. S. (1984). HODGKINS-DISEASE IN PATIENTS OVER 60 YEARS OLD. ANNALS OF INTERNAL MEDICINE, 100(1), 13–18.

CENTRAL NERVOUS-SYSTEM INVOLVEMENT IN NON-HODGKINS LYMPHOMA - AN ANALYSIS OF 105 CASES
MacKintosh, F. R., Colby, T. V., PODOLSKY, W. J., Burke, J. S., Hoppe, R. T., Rosenfelt, F. P., … KAPLAN, H. S. (1982). CENTRAL NERVOUS-SYSTEM INVOLVEMENT IN NON-HODGKINS LYMPHOMA - AN ANALYSIS OF 105 CASES. CANCER, 49(3), 586–95.

STAGE-IIB HODGKINS-DISEASE - THE STANFORD EXPERIENCE
CRNKOVICH, M. J., Hoppe, R. T., & Rosenberg, S. A. (1986). STAGE-IIB HODGKINS-DISEASE - THE STANFORD EXPERIENCE. JOURNAL OF CLINICAL ONCOLOGY, 4(4), 472–479.

THE MANAGEMENT OF STAGE-I-II HODGKINS-DISEASE WITH IRRADIATION ALONE OR COMBINED MODALITY THERAPY - THE STANFORD EXPERIENCE
Hoppe, R. T., Coleman, C. N., Cox, R. S., Rosenberg, S. A., & KAPLAN, H. S. (1982). THE MANAGEMENT OF STAGE-I-II HODGKINS-DISEASE WITH IRRADIATION ALONE OR COMBINED MODALITY THERAPY - THE STANFORD EXPERIENCE. BLOOD, 59(3), 455–465.

FACTORS PREDICTING SURVIVAL IN ADULTS WITH STAGE I AND II LARGE-CELL LYMPHOMA TREATED WITH PRIMARY RADIATION-THERAPY
Kaminski, M. S., Coleman, C. N., Colby, T. V., Cox, R. S., & Rosenberg, S. A. (1986). FACTORS PREDICTING SURVIVAL IN ADULTS WITH STAGE I AND II LARGE-CELL LYMPHOMA TREATED WITH PRIMARY RADIATION-THERAPY. ANNALS OF INTERNAL MEDICINE, 104(6), 747–756.

CUTANEOUS MALIGNANT-MELANOMA AFTER HODGKINS-DISEASE
TUCKER, M. A., MISFELDT, D., Coleman, C. N., Clark, W. H., & Rosenberg, S. A. (1985). CUTANEOUS MALIGNANT-MELANOMA AFTER HODGKINS-DISEASE. ANNALS OF INTERNAL MEDICINE, 102(1), 37–41.

DIFFUSE HISTIOCYTIC LYMPHOMA PRESENTING WITH GASTROINTESTINAL-TRACT LESIONS - THE STANFORD EXPERIENCE
Rosenfelt, F., & Rosenberg, S. A. (1980). DIFFUSE HISTIOCYTIC LYMPHOMA PRESENTING WITH GASTROINTESTINAL-TRACT LESIONS - THE STANFORD EXPERIENCE. CANCER, 45(8), 2188–2193.

A DOSE AND TIME RESPONSE ANALYSIS OF THE TREATMENT OF HODGKINS-DISEASE WITH MOPP CHEMOTHERAPY
Carde, P., MacKintosh, F. R., & Rosenberg, S. A. (1983). A DOSE AND TIME RESPONSE ANALYSIS OF THE TREATMENT OF HODGKINS-DISEASE WITH MOPP CHEMOTHERAPY. JOURNAL OF CLINICAL ONCOLOGY, 1(2), 146–153.

Breast Imaging in Women Previously Irradiated for Hodgkin Lymphoma.
Horst, K. C., Fero, K. E., Hancock, S. L., Advani, R. H., Ikeda, D. M., Daniel, B., … Hoppe, R. T. (2016). Breast Imaging in Women Previously Irradiated for Hodgkin Lymphoma. American Journal of Clinical Oncology, 39(2), 114–19.

Prognostic factors and patterns of failure in advanced stage Hodgkin lymphoma treated with combined modality therapy.
Moding, E. J., Advani, R., Rosenberg, S. A., & Hoppe, R. T. (2018). Prognostic factors and patterns of failure in advanced stage Hodgkin lymphoma treated with combined modality therapy. Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology, 129(3), 507–12.

EVIDENCE FOR AN ORDERLY PROGRESSION IN SPREAD OF HODGKINS DISEASE
ROSENBERG, S. A., & KAPLAN, H. S. (1966). EVIDENCE FOR AN ORDERLY PROGRESSION IN SPREAD OF HODGKINS DISEASE. CANCER RESEARCH, 26(6P1), 1225-+.

CONTRIBUTION OF LYMPHANGIOGRAPHY TO OUR UNDERSTANDING OF LYMPHOMA
ROSENBERG, S. A. (1968). CONTRIBUTION OF LYMPHANGIOGRAPHY TO OUR UNDERSTANDING OF LYMPHOMA. CANCER CHEMOTHERAPY REPORTS, 52(1), 213-+.

EFFECT OF PRIOR SEDATION ON NITROGEN MUSTARD EFFECT IN RAT
ROSENBERG, S. A. (1962). EFFECT OF PRIOR SEDATION ON NITROGEN MUSTARD EFFECT IN RAT. CANCER, 15(6), 1170-&.

EXTENDED-FIELD RADICAL RADIOTHERAPY IN ADVANCED HODGKINS DISEASE - SHORT-TERM RESULTS OF 2 RANDOMIZED CLINICAL TRIALS
KAPLAN, H. S., & ROSENBERG, S. A. (1966). EXTENDED-FIELD RADICAL RADIOTHERAPY IN ADVANCED HODGKINS DISEASE - SHORT-TERM RESULTS OF 2 RANDOMIZED CLINICAL TRIALS. CANCER RESEARCH, 26(6P1), 1268-+.

REPORT OF COMMITTEE ON STAGING OF HODGKINS DISEASE
ROSENBERG, S. A. (1966). REPORT OF COMMITTEE ON STAGING OF HODGKINS DISEASE. CANCER RESEARCH, 26(6P1), 1310-+.